148 related articles for article (PubMed ID: 6641224)
1. Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
Stanczyk FZ; Mroszczak EJ; Ling T; Runkel R; Henzl M; Miyakawa I; Goebelsmann U
Contraception; 1983 Sep; 28(3):241-51. PubMed ID: 6641224
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of norethindrone and ethinyl estradiol for two different weight tablets with the same hormonal content.
Saperstein S; Edgren RA; Ellis DJ; Lee GJ; Kushinsky S; Olmsted A; Mroszczak E
Contraception; 1986 Jun; 33(6):547-57. PubMed ID: 3769481
[TBL] [Abstract][Full Text] [Related]
3. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.
Stanczyk FZ; Gale JA; Goebelsmann U; Nerenberg C; Matin S
Contraception; 1980 Nov; 22(5):457-70. PubMed ID: 7471737
[TBL] [Abstract][Full Text] [Related]
5. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
6. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
[TBL] [Abstract][Full Text] [Related]
8. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
9. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.
Saperstein S; Edgren RA; Lee GJ; Jung D; Fratis A; Kushinsky S; Mroszczak E; Dorr A
Contraception; 1989 Nov; 40(5):581-90. PubMed ID: 2612166
[TBL] [Abstract][Full Text] [Related]
11. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
Garza-Flores J; Diaz-Sanchez V; Jimenez-Thomas S; Rudel HW
Contraception; 1984 Oct; 30(4):371-9. PubMed ID: 6509988
[TBL] [Abstract][Full Text] [Related]
12. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
el-Raghy I; Back DJ; Makeram M; Salem H; Osman F; Fathalla M; Orme ML
Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
[TBL] [Abstract][Full Text] [Related]
14. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR
Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.
Vose CW; Butler JK; Williams BM; Stafford JE; Shelton JR; Rose DA; Palmer RF; Breckenridge AM; Orme ML; Serlin MJ
Contraception; 1979 Feb; 19(2):119-27. PubMed ID: 428229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
17. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
Zacur HA; Burkman RT; Kimball AW; Kwiterovich P; Bell WR
J Clin Endocrinol Metab; 1992 Nov; 75(5):1268-72. PubMed ID: 1430087
[TBL] [Abstract][Full Text] [Related]
18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral contraceptive steroids after morning or evening administration.
Kiriwat O; Fotherby K
Contraception; 1983 Feb; 27(2):153-60. PubMed ID: 6851554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
